Format

Send to

Choose Destination
Biosens Bioelectron. 2011 Dec 15;30(1):272-5. doi: 10.1016/j.bios.2011.09.025. Epub 2011 Sep 29.

Label free and amplified detection of cancer marker EBNA-1 by DNA probe based biosensors.

Author information

1
Biofunctional Nanomaterials Department, CIC biomaGUNE, Donostia, San Sebastian, 20009, Spain.

Erratum in

  • Biosens Bioelectron. 2012 Mar 15;33(1):313.

Abstract

Epstein-Barr virus (EBV) is a human herpes virus that has been associated with several malignancies as Burkitt's lymphoma, nasopharyngeal carcinoma and Hodgkin's disease. All EBV associated malignancies showed a distinct viral gene expression pattern, while Epstein-Barr nuclear antigen 1 (EBNA-1) is constitutively expressed in all such disorders. Here, the development of a biosensor to detect EBNA-1 protein is reported, which was based on a nucleic acid bioreceptor and a quartz crystal microbalance with a dissipation monitoring (QCM-D) transducer. The DNA probe for EBNA-1 detection was designed and synthesized to mimic its palindromic target sites in the EBV genome. This DNA probe was immobilized on the Au-surface of a QCM-D electrode, followed by the blocking of the accessible Au-surface with 6-mercapto-1-hexanol (6-MHO). The system showed a limit of detection of 50 ng/mL in direct detection of EBNA-1, however, the sensitivity was improved by 2 orders of magnitude (0.5 ng/mL) when an amplification cascade, employing antibodies labeled with alkaline phosphatase (AP), was applied to the system.

PMID:
22014418
DOI:
10.1016/j.bios.2011.09.025
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center